Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Inv. presentation
Consulting agrmnt
Director departure
NANOSPHERE INC (NSPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2016 8-K Quarterly results
06/27/2016 8-K Form 8-K - Current report
06/01/2016 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Second Amendment to Merger Agreement"
05/24/2016 8-K Form 8-K - Current report
05/23/2016 8-K Form 8-K - Current report
05/23/2016 8-K Form 8-K - Current report
05/20/2016 8-K Form 8-K - Current report
05/18/2016 8-K Form 8-K - Current report
05/17/2016 8-K Form 8-K - Current report
05/16/2016 8-K Form 8-K - Current report
05/16/2016 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, among Luminex Corporation, Commodore Acquisition, Inc., and Nanosphere, Inc",
"Form of support agreement",
"JOINT PR"
04/22/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/24/2016 8-K Quarterly results
Docs: "2015 YEAR END PRESS RELEASE"
01/29/2016 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
01/06/2016 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "PRE-RELEASE"
12/22/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Securities Purchase Agreement by and between Nanosphere, Inc. and the investors party thereto",
"NANOSPHERE, INC. ANNOUNCES COMPLETION OF $10 MILLION REGISTERED PUBLIC OFFERING NORTHBROOK, Ill — December 22, 2015 - Nanosphere, Inc. , a company enhancing medicine through targeted and flexible molecular diagnostics, today announced the completion of its previously announced public offering of the company's common stock for total gross proceeds of approximately $10 million. The offering was priced at $0.47 per share of common stock , with each share of common stock coupled with a five-year warrant to purchase one share of common stock, at an exercise price of $0.70 per share. Rodman & Renshaw, a unit of H.C. Wainwright & Co., acted as the sole book runner in connection with the offering. Joseph Gunnar & Co. acted as a co-manager and LifeSci Capital LLC acted as a financial advisor in con..."
12/18/2015 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financi...
Docs: "Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock of Nanosphere, Inc.",
"Form of Series A Warrant",
"Form of Compensation Warrant",
"Specimen stock certificate for Series C Convertible Preferred Stock",
"Securities Purchase Agreement by and between Nanosphere, Inc. and the investors party thereto",
"NANOSPHERE, INC. ANNOUNCES $10 MILLION REGISTERED PUBLIC OFFERING NORTHBROOK, Ill — December 17, 2015 - Nanosphere, Inc. , a company enhancing medicine through targeted and flexible molecular diagnostics, today announced the pricing of a public offering of the company's common stock with expected total gross proceeds of approximately $10 million. The offering is expected to close on or about December 22, 2015, subject to satisfaction of customary closing conditions. The offering was priced at $0.47 per share of common stock , with each share of common stock coupled with a five-year warrant to purchase one share of common stock, at an exercise price of $0.70 per share. Rodman & Renshaw, a unit of H.C. Wainwright & Co., acted as the sole book runner in connection with the offering. Joseph Gu..."
12/10/2015 8-K Investor presentation
Docs: "Investor Presentation"
12/08/2015 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of warrant to purchase common stock",
"Second Amendment to Loan and Security Agreement among NSPH Funding LLC, as collateral agent, and NSPH Funding LLC and SWK Funding LLC, as Lenders, and the Company",
"Registration Rights Agreement among NSPH Funding LLC, SWK Funding LLC, and the Company"
11/09/2015 8-K Quarterly results
Docs: "Nanosphere Announces Record Q3 2015 Results"
10/02/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/10/2015 8-K Quarterly results
Docs: "Q2-15 EARNINGS RELEASE"
07/31/2015 8-K Financial Statements and Exhibits
Docs: "First Amendment to Loan and Security Agreement",
"Nanosphere Announces Amendment to $30 million term loan facility, Release of Q2 2015 results and Conference Call and Schedules 2015 Annual Meeting of Stockholders"
06/11/2015 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...
Docs: "Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock of Nanosphere, Inc.",
"Warrant to purchase common stock issued to Sabby Healthcare Master Fund, Ltd",
"Warrant to purchase common stock issued to Sabby Volatility Warrant Master Fund, Ltd",
"Warrant to purchase common stock issued to H.C. Wainwright & Co, LLC",
"Warrant to purchase common stock issued to Noam Rubinstein",
"Warrant to purchase common stock issued to Michael Vasinkevich",
"Warrant to purchase common stock issued to Mark Viklund",
"Warrant to purchase common stock issued to Charles Worthman",
"Specimen stock certificate for Series B Convertible Preferred Stock",
"Opinion of Seyfarth Shaw LLP"
06/08/2015 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Nanosphere Announces $4.4 Million At The Market Registered Direct Offering"
06/02/2015 8-K Entered into consulting agreement
Docs: "Agreement between Nanosphere, Inc. and Chord Advisors, LLC"
05/14/2015 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
Docs: "Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock of Nanosphere, Inc.",
"Warrant to purchase common stock issued to NSPH Funding LLC",
"Warrant to purchase common stock issued to SWK Funding LLC",
"Warrant to purchase common stock issued to Sabby Healthcare Master Fund, Ltd",
"Warrant to purchase common stock issued to Sabby Volatility Warrant Master Fund, Ltd",
"Warrant to purchase common stock issued to H.C. Wainwright & Co, LLC",
"Warrant to purchase common stock issued to Noam Rubinstein",
"Warrant to purchase common stock issued to Michael Vasinkevich",
"Warrant to purchase common stock issued to Mark Viklund",
"Warrant to purchase common stock issued to Charles Worthman"
05/11/2015 8-K Quarterly results
Docs: "Nanosphere Announces Record Q1 2015 Results, New and Expanded Debt Facility, $4.4 Million At The Market Registered Direct Offering and Next Generation Verigene System Progress Corporate Highlights:"
04/07/2015 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Certificate of Amendment to Certificate of Incorporation of Nanosphere, Inc",
"Nanosphere Announces Reverse Split of Common Stock"
02/11/2015 8-K Quarterly results
Docs: "Nanosphere Announces Fourth Quarter and Full Year 2014 Results, 2015 Guidance and Next Generation Verigene Progress Corporate Highlights and Guidance:"
01/28/2015 8-K Resignation/termination of a director
Docs: "Nanosphere Announces Fourth Quarter and Full Year 2014 Preliminary Top Line Results, Director and Management Changes and Receipt of FDA Warning Letter",
"Letter from the U.S. Food and Drug Administration to Nanosphere, Inc."
11/05/2014 8-K Quarterly results
Docs: "Nanosphere Announces Third Quarter Financial and Operating Results"
10/27/2014 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Underwriting Agreement by and between Nanosphere, Inc. and Chardan Capital Markets, LLC, as representative of the several underwriters",
"Opinion of Seyfarth Shaw LLP",
"Nanosphere, Inc. Announces the Closing of Common Stock Offering"
10/22/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Press Release of Nanosphere, Inc."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy